Inhibrx Biosciences (INBX) Non-Current Assets (2023 - 2025)
Historic Non-Current Assets for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $16.0 million.
- Inhibrx Biosciences' Non-Current Assets rose 616.57% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.8 million, marking a year-over-year change of. This contributed to the annual value of $20.4 million for FY2024, which is 6249.7% up from last year.
- Inhibrx Biosciences' Non-Current Assets amounted to $16.0 million in Q3 2025, which was up 616.57% from $18.2 million recorded in Q2 2025.
- Inhibrx Biosciences' 5-year Non-Current Assets high stood at $20.4 million for Q4 2024, and its period low was $12.5 million during Q4 2023.
- Its 3-year average for Non-Current Assets is $16.8 million, with a median of $16.4 million in 2024.
- Per our database at Business Quant, Inhibrx Biosciences' Non-Current Assets skyrocketed by 6249.7% in 2024 and then surged by 616.57% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Non-Current Assets (Quarter) stood at $12.5 million in 2023, then skyrocketed by 62.5% to $20.4 million in 2024, then dropped by 21.21% to $16.0 million in 2025.
- Its Non-Current Assets was $16.0 million in Q3 2025, compared to $18.2 million in Q2 2025 and $19.3 million in Q1 2025.